From: Avoiding hERG-liability in drug design via synergetic combinations of different (Q)SAR methodologies and data sources: a case study in an industrial setting
Expert model
ACC
BA
SENS
SPEC
PPV
NPV
MCC
KAPPA
Derek Nexus
0.75
0.63
0.43
0.84
0.44
0.27